tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR2100047659】THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.

    基本信息
    登记号

    ChiCTR2100047659

    试验状态

    结束

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2021-06-21

    临床申请受理号

    /

    靶点

    /

    适应症

    Gallbladder polyps

    试验通俗题目

    THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.

    试验专业题目

    THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    01000

    联系人通讯地址
    临床试验信息
    试验目的

    To determine a new algorithm in the diagnosis and treatment of gallbladder

    试验分类
    试验类型

    连续入组

    试验分期

    探索性研究/预试验

    随机化

    Ninety patients (MAN/WOMAN) diagnosed with gallbladder polyp by abdominal ultrasonography between December 2017 and November 2020 were included in the study

    盲法

    N/A

    试验项目经费来源

    Writers

    试验范围

    /

    目标入组人数

    11

    实际入组人数

    /

    第一例入组时间

    2020-11-18

    试验终止时间

    2020-11-18

    是否属于一致性

    /

    入选标准

    Ninety patients diagnosed with gallbladder polyp by abdominal ultrasonography between December 2017 and November 2020 were included in the study；

    排除标准

    Patients who were diagnosed with polyps in an external center, whose cholesterol levels and tumor markers were not tested before the operation, and who had undergone previous interventional procedures to the gallbladder were excluded from the study.；

    研究者信息
    研究负责人姓名
    试验机构

    Nazmi OZER

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    01000

    联系人通讯地址

    土耳其Adana city training and research hospital General surgery department的其他临床试验

    更多
    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品